ALFA Finder| Revenue growth | 16.2% YoY growth in revenue from operations |
|---|---|
| Margins | EBITDA margin softened to 19.3% from 22.2% YoY |
| Demand visibility | Strong footfall at Dombivli; healthy occupancy in established hospitals |
| Management confidence | High; citing steady occupancy ramp-up and insurance empanelment |
Growth
Revenue grew to Rs 411 Cr (up 16.4% YoY); EBITDA remained stable at Rs 79.3 Cr despite initial ramp-up losses.
Outlook
Scaling capacity from 1,700 to 2,900 beds via greenfield projects in Pune, Mira Road, and BKC.
Risks
EBITDA impacted by Rs 9.5 Cr Dombivli loss; higher interest and depreciation from ongoing expansion.
Last quarter's promises, checked
Delivered
- Dombivli commissioning by Q1 FY27 → delivered Feb 2026 (= BEAT)
- Dombivli EBITDA burn INR 2-3 Cr/month → delivered INR 3.1 Cr/month (= BEAT)
- Asset-heavy model capex ~INR 1.5 Cr/bed → delivered ~INR 1.5 Cr/bed (= BEAT)
Partly delivered
- Dombivli insurance empanelment 6-12 months → delivered ongoing Q1FY27 (= PARTIAL)
Investor Presentation filed with BSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹287.40
- Market cap
- ₹9,422 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 50.5×Sector 54.5×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Jupiter Lifeline reports strong growth with Q2 revenue of ₹456.5 Cr and EBITDA of ₹106.9 Cr. Management prioritizes asset ownership, recently acquiring the Pune South hospital land for ₹150 Cr.
Jupiter Life Line Hospitals Acquisition Worth ₹150 Cr
Jupiter Life Line Hospitals executed a sale agreement to acquire 11,452.07 sq m of land in Pune for Rs 150 Crore. The land is where its South Pune hospital project is under development.
- Value
- ₹150.0 Cr
Jupiter Life Line Hospitals Capacity Expansion: ₹0.01 Cr Investment
Jupiter Life Line Hospitals will hold 100% of newly incorporated subsidiary Holitti Private Limited, a healthcare services entity. The subscription is for paid-up capital of Rs 1,00,000, about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹0.01 Cr
Jupiter Life Line Hospitals will incorporate wholly owned subsidiary Holitti Private Limited for healthcare services, subscribing Rs 1 lakh. It will run laboratory and healthcare services.
- Value
- ₹0.01 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 436.3 cr (+15.8% YoY), EBITDA Rs 106.9 cr (23.4% margin), PAT Rs 56.4 cr (-1.7%) on Dombivli ramp-up, depreciation and finance costs. Bed capacity expanding from 1,700 to 2,900.
Jupiter Life Line Hospitals Q2 FY27 Results: Net Profit ₹56.4 Cr, Down 1.9% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹456.5 Cr (+16.0% YoY) and net profit of ₹56.4 Cr (-1.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹56.4 Cr · -1.9% YoY